Gastric Bypass Cuts Diabetes in Mild Obesity
Gastric Bypass Cuts Diabetes in Patients noticed decline in glycated hemoglobin within the first six months of surgery.
Gastric bypass may be an effective treatment for type 2 diabetes in patients who are only mildly obese, researchers said here.
The vast majority of patients (88 percent) had remission of their diabetes, bringing their glycated hemoglobin (HbA1c) to 6.5 percent, even after coming off their anti-diabetic drugs, David Cummings, MD, of the University of Washington in Seattle, and colleagues reported online in Diabetes Care and during a session at the American Diabetes Association meeting here.
An additional 11 percent achieved an HbA1c below 7 percent while decreasing their use of oral diabetic drugs and withdrawal of insulin, they found.
Gastric bypass “is a safe, effective procedure to ameliorate type 2 diabetes and associated comorbidities,” they wrote, adding that their findings justify further trials to clarify whether bypass “should be broadened and might be viewed primarily as a ‘metabolic’ rather than ‘bariatric’ surgery.”
Severely obese patients are often rid of their type 2 diabetes when they have gastric bypass surgery. An NIH consensus statement, however, limits the use of bariatric surgery to patients with a body mass index (BMI) of at least 35 kg/m2 in addition to comorbidities, the researchers said.
To read the rest of the article click the link: http://bit.ly/2kLjFmE